nav Searchuser
Hebei Lansheng Biotech Co., Ltd.
Beijing Multigrass Formulation Co., Ltd.

Noposion: net profit down by 91.4% YoY to USD2.9 million in H1 2016qrcode

Sep. 12, 2016

Favorites Print
Forward
Sep. 12, 2016
By Think Real - Shenzhen Noposion Agrochemical Co., Ltd. (Noposion, the largest pesticide formulations manufacturer in China) released its H1 2016 financial report. Specifically, it made the revenue of USD227.7 million, up by 4.2% YoY and net profit USD2.9 million, down by 91.4% YoY.
 
Increased costs in establishing Tian Tian Quan online platform
 
In H1, Noposion continuously advanced the smooth development of Internet based Tian Tian Quan ecological platform: 1,200 direct-sale stores were newly built. In particular, it licensed brand to 400+ stores, signed nearly 300, participated (by share, each at a 35% stake) in nearly 200 and controlled 11 (by share, each at a 51% stake). Besides, it opened 2,200+ Tian Tian Quan agricultural service stores in 400+ counties, 28 provinces / regions / municipalities.
 
Regarding rise in revenue and fall in net profit, Noposion attributed it to the growth of 33.3% in cost of sales, which was caused by acquisition activities. In H1, the company made a total investment of USD16.2 million for external business, down by 48.4% YoY. However, it input largely in expanding distribution channels. Only within January-June, it invested in 24 distribution companies such as Puyang Yulong Agricultural Service Co., Ltd.
 
Declines in gross profit margins for all products
 
During this period, key products including insecticides, fungicides, herbicides, plant nutritionals and promoters all recorded falls in gross profit margins, particularly by 1.1 percentage points, 1.9 percentage points and 17.6 percentage points respectively in insecticides, fungicides and herbicides. Noposion also ascribed this to the acquisitions of distribution companies, “They were commonly marketing products of comparatively low gross profit margins, which pushed down the overall performance.”
 
However, Noposion believed that it performed fairly well in this period, “We set strategic goals early this year. In addition to consolidating its position in traditional pesticide formulations segment, we made efforts to explore and optimise business models, and create new sources for profit growth.”
 
Table 1: Revenue and gross margin of main business of Noposion, H1 2016
Item
Revenue,
million USD
YoY change
Gross margin
YoY change,
percentage points
By product
Insecticides
86.7
0.49%
38.6%
-1.1
Fungicides
75.9
10.2%
43.5%
-1.9
Herbicides
35.2
-20.0%
16.0%
-17.6
Crop nutrients
22.8
32.5%
30.9%
-9.2
Additives
1.4
48.8%
38.1%
-13.6
Brand services
1.2
/
/
/
Other
(in agrochemical)
4.2
303.4%
16.9%
9.5
Others
0.26
42.9%
71.4%
37.9
By region
Northeast China
14.3
-7.8%
34.6%
-4.4
North China
17.9
1.8%
34.9%
-5.7
East China
72.2
16.2%
37.2%
-3.0
South China
27.5
-22.8%
36.1%
-4.0
Central China
27.8
-3.3%
36.0%
-4.8
Northwest China
28.1
11.8%
34.9%
-5.7
Southwest China
37.5
16.8%
34.7%
-4.8
Overseas
2.0
35.7%
38.7%
-8.4
Others
0.26
42.9%
71.4%
37.9
Source: Noposion
 
Source: Think Real

Picture 0/1200

More from AgroNews

Magazine

2020 Formulation & Adjuvant Technology Annual Review 2019
Chinese issue of Annual Review 2019 2019 CRO & CRAO Manual
2019 Market Insight Chinese issue of 2019 Market Insight
I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

Picture 0/1200

Subscribe to daily email alerts of AgroNews.